title: [What is the real value of antiaggregation therapy in the prevention of ischemic cerebral infarction? Reflections and suggestions].
authors.forename: G G
authors.initials: GG
authors.lastname: Neri Serneri
authors.forename: G F
authors.initials: GF
authors.lastname: Gensini
authors.forename: A
authors.initials: A
authors.lastname: Fortini
authors.forename: L
authors.initials: L
authors.lastname: Amaducci
authors.forename: D
authors.initials: D
authors.lastname: Inzitari
mesh_terms: D001241:Aspirin / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000150:complications / Q000517:prevention & control; D002544:Cerebral Infarction / Q000209:etiology / Q000517:prevention & control*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D002546:Ischemic Attack, Transient / Q000150:complications / Q000517:prevention & control; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D012307:Risk Factors
chemical_list: D010975:Platelet Aggregation Inhibitors; D006493:Heparin; D001241:Aspirin
vernacular_title: Qual'è il reale valore della terapia antiaggregante nella prevenzione dell'infarto cerebrale ischemico? Riflessioni e suggerimenti.